Targeting the CCL2/CCR2 axis has previously been shown to inhibit HCC tumour growth and metastasis by reducing monocyte and TAM infiltration and increasing CD8+ T-cell cytotoxic activity [68]. This evidence concerns the gene CCL2 and hepatocellular carcinoma.